Skip to content
Companies

Syndex Bio

Pioneering biotechnology company dedicated to revolutionizing the pace and depth of biological discovery through the application of advanced technologies

Raised to date

$15.5M

of $15.5M offered across 1 Form D filing

Investors
12
Last filed
Mar 14, 2025

About

Established in 2022 and located in Cambridge, UK, the company focuses on creating innovative tools designed to enhance research capabilities across various fields in biology and medicine.

Syndex Bio stands out by integrating molecular technologies with artificial intelligence, enabling researchers to achieve insights faster than traditional methods.

Funding

  • EquityFiled Mar 14, 2025Form D
    $15.5M/ $15.5M

Product

Syndex AI Platform

Research Platform

The Syndex AI Platform is a comprehensive solution that merges molecular technologies, advanced instrumentation, and artificial intelligence to facilitate the analysis of biological samples. It designed to streamline the research workflow, allowing for more efficient data processing and deeper insights.

  • Integration of molecular analysis techniques with AI
  • Accelerated data processing for timely results
  • User-friendly interface for researchers

Built for

Academic and commercial research institutions

People on file